Close-up of the Alpha-IMS. The implant provided "useful vision" in more than half of the nine patients tested in the first phase of a multi-center clinical trial. However, after around nine months three had the device removed when the chip's periphery corroded - the result of broken hermetic seals. Credit: Retina Implant. |
© 2024 SPIE Europe |
|